Page last updated: 2024-12-06

croneton

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

croneton: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID34766
CHEMBL ID493480
CHEBI ID38483
SCHEMBL ID74938
MeSH IDM0058261

Synonyms (73)

Synonym
caswell no. 263aa
carbamic acid, methyl-, alpha-(ethylthio)-o-tolyl ester
einecs 249-981-9
arylmate
ethiophencarbe [iso-french]
2-ethylthiomethylphenyl n-methylcarbamate
(2-ethylthiomethyl-phenyl)-n-methylcarbamate
ethiofencarb [bsi:iso]
croneton 500
ai3-29007
phenol, 2-((ethylthio)methyl)-, methylcarbamate
2-ethyl-mercaptomethyl-phenyl-n-methylcarbamate
alpha-(ethylthio)-o-tolyl methylcarbamate [iso:bsi]
brn 2973224
chox 1901
bay-hox-1901
kronetone
hox 1901
epa pesticide chemical code 112101
carbamic acid, methyl-, 2-(ethylthiomethyl)phenyl ester
hsdb 7140
alpha-(ethylthio)-o-tolyl methylcarbamate
29973-13-5
2-((ethylthio)methyl)phenyl methylcarbamate
croneton
ethiofencarb
CHEBI:38483 ,
2-[(ethylsulfanyl)methyl]phenyl methylcarbamate
2-((ethylthio)methyl)phenol methylcarbamate
alpha-ethylthio-o-tolyl methylcarbamate
NCGC00163882-01
bdbm50253090
[2-(ethylsulfanylmethyl)phenyl] n-methylcarbamate
CHEMBL493480 ,
inchi=1/c11h15no2s/c1-3-15-8-9-6-4-5-7-10(9)14-11(13)12-2/h4-7h,3,8h2,1-2h3,(h,12,13)
heznviyqeuhlni-uhfffaoysa-
C18649
tox21_301356
NCGC00255441-01
dtxsid3037545 ,
cas-29973-13-5
dtxcid1017545
fy0yb813xv ,
ethiophencarbe
unii-fy0yb813xv
carbamic acid, methyl-,2-(ethylthiomethyl)phenyl ester
AKOS015888329
phenol, 2-((ethylthio)methyl)-, 1-(n-methylcarbamate
.alpha.-(ethylthio)-o-tolyl methylcarbamate
croneton-500
ethiofencarb [hsdb]
bay-hox 1901
carbamic acid, methyl-, .alpha.-(ethylthio)-o-tolyl ester
chox-1901
ethiofencarb [iso]
2-((ethylthio)methyl)phenyl n-methylcarbamate
hox-1901
o-cresol, .alpha.-(ethylthio)-, methylcarbamate
.alpha.-ethylthio-o-tolyl methylcarbamate
SCHEMBL74938
phenol, 2-[(ethylthio)methyl]-, methylcarbamate
2-[(ethylsulfanyl)methyl]phenyl n-methylcarbamate
ethiofencarb, pestanal(r), analytical standard
mfcd00055463
2-[(ethylthio)methyl]phenyl n-methylcarbamate
ethiofencarb 100 microg/ml in cyclohexane
2-(ethylthiomethyl)phenyl methylcarbamate, 9ci
phenol, 2-((ethylthio)methyl)-, methylcarbamate (9ci)
n-methyl-o-(2-ethylthiomethyl) phenylcarbamate
J-017713
alpha-ethylthio-o-tolylmethyl carbamate
2-(ethylthiomethyl)phenyl methylcarbamate
Q3591963
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
carbamate insecticideDerivatives of carbamic acid with insecticidal properties of general formula ROC(=O)NR(1)R(2), where ROH is an alcohol, oxime, or phenol and R(1) is hydrogen or methyl. Like organophosphate insecticides, they are cholinesterase inhibitors, but carbamate insecticides differ in action from the organophosphates in that the inhibitory effect on cholinesterase is generally brief.
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency17.49230.002541.796015,848.9004AID1347395; AID1347397; AID1347398
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency15.31110.001022.650876.6163AID1224838; AID1224839; AID1224893
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency0.19490.000214.376460.0339AID720691
pregnane X nuclear receptorHomo sapiens (human)Potency70.79460.005428.02631,258.9301AID720659
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency34.37620.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Hormone-sensitive lipaseRattus norvegicus (Norway rat)IC50 (µMol)0.37000.37001.27003.2500AID390722
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
lipid dropletHormone-sensitive lipaseRattus norvegicus (Norway rat)
cytosolHormone-sensitive lipaseRattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID390724Inhibition of HSL in Wistar rat isolated fat cells at 10 uM by spectrophotometric assay2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors.
AID390722Inhibition of HSL in Wistar rat isolated fat cells by spectrophotometric assay2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
Combining ligand-based pharmacophore modeling, quantitative structure-activity relationship analysis and in silico screening for the discovery of new potent hormone sensitive lipase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (36.36)18.7374
1990's4 (36.36)18.2507
2000's2 (18.18)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.47 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (19.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (8.33%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]